Project Details
Abstract
Precision medicine encompasses the development of patient-specific therapeutic regimes based on their genetic background, lifestyle choices, and environmental exposure. In this regard, massive efforts have been undertaken to sequence the genomes of as many individuals as possible, both in Qatar and in other countries in the world. However, effective precision medicine therapy development will require a concomitant development of technologies that allow the determination of various physiological parameters that complement genetic information, thus aid decisions related to therapy. There have been great advances in sensing technologies, including optical, bioimpedance and nanothermometer, etc., miniaturizing and making them available for wide-scale deployment in non-clinical settings, and thus enabling wide-scale biomedically relevant parameter monitoring continues to be a challenge. In this project, we will develop a high-dynamicrange bioluminescence and fluorescence instrumentation system using customized photoreceptor and readout circuits. The system will be used for discovering and characterizing allosteric inhibitors of the SARSCoV-2 Mpro protease. It will also be used to decode the role of coevolving residues in cGMP-mediated allostery in PDE5, which is a major pharmacological target for treating diseases such as pulmonary hypertension and erectile dysfunction, with the aim of developing a new class of PDE5 modulators for precision medicine application.
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
Sponsor's Award Number | VPR-TG01-007 |
---|---|
Proposal ID | HBKU-OVPR-TG-01-7 |
Status | Finished |
Effective start/end date | 1/06/21 → 15/11/23 |
Primary Theme
- Precision Health
Primary Subtheme
- PH - Diagnosis Treatment
Secondary Theme
- Sustainability
Secondary Subtheme
- SU - Wellbeing
Keywords
- None
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.